The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

By C. Neunert, W. Lim, Mark Crowther, A. Cohen, L. Solberg. Blood, 2011

1,860 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology

View Paper: https://www.semanticscholar.org/paper/165f5044e75ad7450cdee412f0f20927c6e5a38e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Malfertheiner
2. F. Mégraud
3. C. O'Morain
4. M. Rugge
5. E. Kuipers
6. J. Atherton
7. E. El-Omar
8. K. Sugano

Citations in the corpus

• American Society of Hematology 2019 guidelines for immune thrombocytopenia. (2019, neutral): ““C” indicates evidence derived from RCTs with serious flaws, weaker observational studies, or indirect evidence.(42)”
• Updated international consensus report on the investigation and management of primary immune thrombocytopenia. (2019, neutral): “Reticulated platelets/immature platelet fraction are thought to reflect platelet production, and these values are elevated in most patients with ITP.”
• Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (2016, background): “76 77 These guidelines currently recommend against routine testing for H. pylori in children with chronic ITP based on con fl icting reports in the literature, although there are some studies that suggest that H. pylori eradication may prove effective in paediatric ITP patients.”